Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages

Atherosclerosis

Volumn 187, Issue 2, 2006, Pages 363-371

  Rosenblat, Mira ^a   Hayek, Tony ^a,b   Aviram, Michael ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Atherosclerosis; Diabetes; Macrophages; Oxidative stress; Pomegranate juice

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; GLUCOSE; GLUTATHIONE; LIPID PEROXIDE; SUGAR; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; FOOD INTAKE; FRUIT JUICE; GLUCOSE BLOOD LEVEL; HUMAN; MACROPHAGE; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; OXIDATIVE STRESS; POMEGRANATE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANTIOXIDANTS; ATHEROSCLEROSIS; C-PEPTIDE; CARBOHYDRATES; CELLS, CULTURED; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FLAVONOIDS; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; OXIDATIVE STRESS; PHENOLS; PLANT EXTRACTS; PUNICACEAE; TRIGLYCERIDES;

EID: 33745495836     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.09.006     Document Type: Article

References (48)

1. Ziegler D. Type 2 diabetes as an inflammatory cardiovascular disorder. Curr Mol Med 5 (2005) 309-322
2. Wattanakit K., Folsom A.R., Selvin E., et al. Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 180 (2005) 389-397
3. Aronson D., and Rayfield E.J. How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol 1 (2002) 1
4. Ceriello A., and Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24 (2004) 816-823
5. Martin-Gallan P., Carrascosa A., Gussinye M., and Dominguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 34 (2003) 1563-1574
6. Whiteside C.L. Cellular mechanisms and treatment of diabetes vascular complications converge on reactive oxygen species. Curr Hypertens Rep 7 (2005) 148-154
7. Johansen J.S., Harris A.K., Rychly D.J., and Ergul A. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol 4 (2005) 5
8. Park S., and Choi S.B. Effects of alpha-tocopherol supplementation and continuous subcutaneous insulin infusion on oxidative stress in Korean patients with type 2 diabetes. Am J Clin Nutr 75 (2002) 728-733
9. Ceriello A., Bortolotti N., Motz E., et al. Red wine protects diabetic patients from metal-induced oxidative stress and thrombosis: a pleasant approach to the prevention of cardiovascular disease in diabetes. Eur J Clin Invest 31 (2001) 322-328
10. Rizvi S.I., Zaid M.A., Anis R., and Mishra N. Protective role of tea catechins against oxidation-induced damage of type 2 diabetic erythrocytes. Clin Exp Pharmacol Physiol 32 (2005) 70-75
11. Gil M.L., Tomas-Barberan F.A., Hess-Pierce B., Holcroft D.M., and Kader A.A. Antioxidant activity of pomegranate juice and its relationship with phenolics composition and processing. J Agric Food Chem 10 (2000) 4581-4589
12. Aviram M. Pomegranate juice as a major source for polyphenolic flavonoids and it is most potent antioxidant against LDL oxidation and atherosclerosis. In: Pasquier C, editor. Proceedings of the XI Biennial Meeting of the Society for Free Radical Research International. Paris, France, 16-20 July, 2002. Monduzzi Editore S.P, A-MEDIMOND Inc., pp. 523-28.
13. Aviram M., Dornfeld L., Rosenblat M., et al. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr 71 (2000) 1062-1076
14. Aviram M., Rosenblat M., Gaitini D., et al. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr 23 (2004) 423-433
15. Boyle J.J. Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. Curr Vasc Pharmacol 3 (2005) 63-68
16. Naito T., Oikawa S., Kotake H., Hayasaka K., and Toyota T. Effect of glucose concentration on foam cell formation in THP-1 cells. J Atheroscler Thromb 8 (2001) 55-62
17. Dobrian A.D., Lazar V., Sinescu C., Mincu D., and Simionescu M. Diabetic state induces lipid loading and altered expression and secretion of lipoprotein lipase in human monocytes-derived macrophages. Atherosclerosis 153 (2000) 191-201
18. Ceolotto G., Gallo A., Miola M., et al. Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo. Diabetes 48 (1999) 1316-1322
19. Ling Li, Tatsuya S., and Genevieve R. Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation. Circ Res 94 (2004) 892-901
20. Fukuhara-Takaki K., Sakai M., Sakamoto Y., Takeya M., and Horiuchi S. Expression of class A scavenger receptor is enhanced by high glucose in vitro under diabetic conditions in vivo: one mechanism for an increased rate of atherosclerosis in diabetes. J Biol Chem 280 (2005) 3355-3364
21. Hayek T, Hussein K, Aviram M, et al. Macrophage foam cell formation in streptozotocin-induced diabetic mice: stimulatory effect of glucose. Atherosclerosis, in press.
22. Gan K.N., Smolen A., Eckerson H.W., and La D.B.N. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 19 (1991) 100-106
23. Frei B., Stocker R., and Ames B.N. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 85 (1988) 9748-9752
24. Buege J.A., and Aust S.D. Microsomal lipid peroxidation. Methods Enzymol 52 (1978) 302-310
25. El-Saadani M., Esterbauer N., El-Sayed M., Goher M., Nassar A.Y., and Jurgens G. Spectrophotometric assay for lipid peroxides in serum lipoproteins using commercially available reagent. J Lipid Res 30 (1989) 627-630
26. Hu M.-L., Dillard C.J., and Tappel A.I. In vivo effects of aurothioglucose and sodium thioglucose on rat tissue sulfhydryl levels and plasma sulfhydryl reactivity. Agents Actions 25 (1988) 132-138
27. LeBel C.P., Ischiropoulos H., and Bondy S.C. Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 5 (1992) 227-231
28. Bass D.A., Parce J.W., Dechatelet L.R., Szejda P., Seeds M.C., and Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 130 (1983) 1910-1917
29. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
30. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: application to mammalian blood and other tissues. Anal Biochem 27 (1969) 502-522
31. Aviram M. Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. Biochem Med 30 (1983) 111-118
32. Aviram M., and Rosenblat M. Paraoxonases 1, 2 and 3, oxidative stress and macrophage foam cells formation during atherosclerosis development. Free Radic Biol Med 37 (2004) 1304-1316
33. Sies H. Glutathione and its role in cellular functions. Free Radic Res 27 (1999) 916-921
34. Fuhrman B., Volkova N., and Aviram M. Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized LDL in macrophage from atherosclerotic mice: protective role of antioxidants and paraoxonase. Atherosclerosis 161 (2002) 307-316
35. Krentz A.J. Lipoprotein abnormalities and their consequences for patients with type 2 diabetes. Diab Obes Metab 5 Suppl. 1 (2003) S19-S27
36. El-Nemr S.E., Ismail I.A., and Ragab M. Chemical composition of juice and seeds of pomegranate fruit. Nahrung 34 (1991) 601-606
37. Ozdemir G., Ozden M., Maral H., Kuskay S., Cetinalp P., and Tarkum I. Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria. Am Clin Biochem 42 (2005) 99-104
38. Knott H.M., Brown B.E., Davies M.J., and Dean R.T. Glycation and glycooxidation of low-density lipoproteins by glucose and low-molecular mass aldehydes. Formation of modified and oxidized particles. Eur J Biochem 270 (2003) 3572-3582
39. Gowri M.S., Van der Westhuyzen D.R., Brodges S.R., and Anderson J.W. Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may be due to the abnormal composition of HDL. Arterioscler Thromb Vasc Biol 19 (1999) 2226-2233
40. Letellier C., Duron M.R., Jouanolle A.M., et al. Serum paraoxonase activity and paraoxonase gene polymorphism in type 2 diabetic patients with or without vascular complications. Diab Metab 28 (2002) 297-304
41. Tsuzura S., Ikeda Y., Suchiro T., et al. Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes. Metabolism 53 (2004) 297-302
42. Aviram M., Rosenblat M., Billecke S., et al. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 26 (1999) 892-904
43. Ferretti G., Bacchetti T., Marchionni C., et al. Effect of glycation of high density lipoproteins on their physiochemical properties and on paraoxonase activity. Acta Diabetol 38 (2001) 163-169
44. Rozenberg O., Shih D.M., and Aviram M. Paraoxonase (1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice. Atherosclerosis 181 (2005) 9-18
45. Fuhrman B., Volkova N., and Aviram M. Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages. Atherosclerosis 16 (2005) 570-576
46. Sampson M.J., Davies I.R., Braschi S., Ivory K., and Hughes D.A. Increased expression of scavenger receptor (CD36) in monocytes from subjects with type 2 diabetes. Atherosclerosis 167 (2003) 120-134
47. Kaplan M., Williams K.J., Mandel H., and Aviram M. Role of macrophage glycosaminoglycans in the cellular catabolism of oxidized LDL by macrophages. Arterioscler Thromb Vasc Biol 4 (1998) 542-553
48. Sah J.F., Balasubramaniam S., Ecker R.L., and Rorke E.A. Epigallocatechin-3-gallate inhibits epidermal grpwth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J Biol Chem 279 (2004) 12755-12762